Elpiscience (Suzhou) Biopharma, Ltd.
Elpiscience (Suzhou) Biopharma, Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study in Adults With Desmoid Tumors | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, connective tissue neoplasm, desmoid tumor, fibroma, neoplasm | Recruiting | Phase 2 | 2026-04-30 | NCT07541430 | |
| A Study of ES102 in Combination With Toripalimab in Subjects With Advanced Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-09-26 | NCT06623136 | |
| A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Phase 1 | 2025-08-13 | NCT05717348 | |
| A Study of ES014 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 2 | 2025-07-30 | NCT06543056 |